To tailor cancer therapies to individual patients, Moderna, BioNTech and other companies are rethinking how they optimize ...

When machine learning is used to suggest new potential scientific insights or directions, algorithms sometimes offer ...

The company will begin its domestic investment by starting construction on a $3 billion pharmaceutical manufacturing site in ...

Merck began construction on a previously announced $3 billion manufacturing facility in Elkton, Va., as the pharmaceutical industry, under pressure from the Trump administration, invests in U.S.

Orocidin A/S, a unit of Nordicus Partners ( OTCQB:NORD ), said on Monday it has developed a cGMP-compliant manufacturing process for its antimicrobial peptide QR-01 in collaboration with Syngene ...

The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use ...

Merck has kicked off construction of a new $3 billion facility at its sprawling manufacturing campus in Elkton, Virginia. | ...

The FDA named the first nine products to undergo a new expedited review process that takes 1 to 2 months, the agency announced on Thursday.

As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product ...

The US Food and Drug Administration on Thursday announced the names of nine products, under a new fast-track review process, ...

As the pharmaceutical sector grows in India, Jamkas Pharmaceuticals emerges as a reliable third-party manufacturer.

Nearly 700 U.S. medicines use at least one chemical solely sourced from China. Experts say there is no financial incentive ...